Zweig-DiMenna Associates’s Imperva, Inc. IMPV Stock Holding History

Zweig-DiMenna Associates’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-137,206	Closed	-$5.27M	–	260
2016 Q4	$5.27M	Buy	+137,206	New	+$5.57M	0.38%	87
2016 Q1	–	Sell	-291,946	Closed	-$18.5M	–	299
2015 Q4	$18.5M	Buy	291,946 +71,666	+33%	+$4.88M	0.92%	40
2015 Q3	$14.4M	Buy	220,280 +164,220	+293%	+$10.9M	0.62%	51
2015 Q2	$3.79M	Buy	+56,060	New	+$3.09M	0.21%	97

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Zweig-DiMenna Associates's IMPV Position: Q1 2017 in Review

Zweig-DiMenna Associates sold out of Imperva, Inc. (IMPV) in Q1 2017, closing a stake of 137,206 shares — an estimated $5.27M sold.

Zweig-DiMenna Associates first reported a position in IMPV in Q2 2015 and held it in 4 quarters. The position peaked at $18.5M in Q4 2015. 182 funds tracked by Wall St. Rank hold IMPV as of Q1 2017.

Zweig-DiMenna Associates reported no remaining Imperva, Inc. position as of Q1 2017 after selling out during the quarter.
Zweig-DiMenna Associates sold 137,206 Imperva, Inc. shares in Q1 2017, an estimated $5.27M.
Zweig-DiMenna Associates first reported a position in Imperva, Inc. in Q2 2015 and held it in 4 quarters.
Zweig-DiMenna Associates's Imperva, Inc. position peaked at $18.5M in Q4 2015.
182 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2017.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2017, filed 8 May 2017.